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Abstract:  There are competing views of how HIV/AIDS affects saving, and to a lesser extent, 
investment. One argument is that saving is reduced because of the disease; the other is that 
saving is actually increased. We find that saving is negatively impacted by the disease in poorer 
countries but increased in relatively wealthy countries. These results, however, do not translate 
through to investment. In fact, the absolute value of the impact the disease has on investment is 
considerably reduced for countries in all income brackets. We hypothesize that because of the 
significant transfer of resources from firms headquartered in relatively wealthy nations to 
subsidiaries and communities in poorer countries much of the negative impact that saving would 
necessarily have on investment is negated.  
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Introduction 
 Halfway through its third decade, HIV/AIDS infections and mortality has topped the 
agenda of international debate due to the severe effects that this disease has on the economic well 
being of nations. In fact, according to the United Nations Program on HIV/AIDS (UNAIDS), in 
2002 it was estimated that 47 million people worldwide were either infected with HIV, or had 
full-blown AIDS. In the same year it was estimated that over 3 million people had died of 
AIDS.1  
 HIV/AIDS erodes the capacity for economic growth and development through lower 
saving and investment, slow employment growth and pressures on government revenues. These 
combine to constrain efforts to prevent worsening poverty, and they may seriously compromise 
the achievement of sustainable socio-economic development in the hardest hit countries. Many 
of these nations have no proper infrastructure to begin with and any potential for infrastructure is 
either being lost or reallocated for disease-related purposes. In particular, job creation and 
employment depend on both domestic and foreign investment. Foreign investment may be 
discouraged by the uncertainty of the economy affected by this epidemic; furthermore, 
substantial domestic investment that could come from saving is lost due to the depletion of the 
workforce, or is being diverted because of the cost associated with treating the disease or burying 
the deceased. 
 It is difficult to measure the impact this epidemic has had on any particular economy, 
especially those that have been hardest hit such as African nations. One measure of this impact is 
reported in the World Banks' United Nations General Assembly Special Session on AIDS 
(UNGASS) Fact Sheet where per capita growth in sub-Saharan countries could fall by 0.5% to 
                                                 
1 http://www.unaids.org/en/default.asp 
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1.2% as a direct result of AIDS.2 The vast majority of studies draw the conclusion that 
HIV/AIDS has ". . . driven many people to penury, and is hindering poor countries from 
achieving their developmental goals" [Edwards and Al-Hmoud, 2004]. One of these goals is an 
increase in domestic saving and hence investment where unfortunately the typical response to the 
epidemic for relatively poor households is to reduce current saving [Bollinger and Stover, 1999; 
Booysen, 2002].  
Effects on Saving 
 The general consensus is that infections reduce saving in two ways--directly and 
indirectly.3 The direct way that saving may be reduced is obviously through higher medical 
expenditures for the treatment of the virus or if the infected is forced out of the work force. 
Indirectly,  infections can lower saving if a family member has to drop out of the workforce to 
take care of a sick loved-one. Whatever the mechanism, this reduction of saving will in turn 
decrease investment and hinder economic growth [Over, 1992; Cuddington, 1993; Bonnel, 2000; 
Dixon et al., 2001; Bollinger and Stover, 1999; Zerfu, 2002; Oni et el., 2002]. 
 On the contrary there is a belief that households with infected members may actually 
increase saving as a precaution for greater future income variability, increased medical expenses, 
and future funeral costs especially in countries where the HIV epidemic is well-established 
[Bonnel, 2000]. Robalino et al., [2002] argues that an infected individual with a high discount 
rate as a result of shorter life expectancy would increase consumption today and therefore reduce 
saving. This also implies that in relatively wealthy countries where HIV drug cocktails are easily 
                                                 
2 http://www.worldbank.org/ungass/factsheet.htm 
3 From this point we use 'infections' rather than 'morbidity' as many authors do because we believe that morbidity 
requires that the individual actually be ill from the disease, whereas infections do not. This fine point is critical when 
observing relatively wealthy nations where an individual can live indefinitely with HIV, but not show any signs of 
illness while simultaneously depleting their saving. 
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accessible and relatively affordable, the individual's discount rate is lower implying relatively 
higher saving than in poorer countries. 
 In terms of mortality, funeral expenditures become an issue and can in fact be very large 
in traditional societies. For example, the typical funeral expense in the United States is $8,000 
for casket and burial4--this figure is over 25% of annual per capita GDP. In addition, relatives 
must leave work and travel to the funeral to pay their last respects with this rite of passage lasting 
days or weeks. The large, one-time expense of the funeral and the loss in time at work for 
relatives further increases the reduction in saving and investment. These expenses, especially the 
expense of traveling and time lost, may be especially large for rural populations where many 
may have to travel for days just to get to the funeral [Oni, S. A., et al., 2002]. 
 In addition to household saving, Breuer [2000] and Zerfu [2002], support the argument 
that a decline in the labor force will lower tax revenues for governments and increase 
expenditures due to high medical costs; this will obviously reduce public saving to a greater 
extent in countries that are hardest hit by the epidemic. Arndt and Lewis [2000, 2001] study the 
impact of HIV/AIDS in South Africa and their conclusion was that by 2010 national savings will 
decline from 17% of GDP to 14.2% of GDP. On the other hand, Haacker [2002] states that in 
general the impact that the disease has on aggregate changes in saving appear to be relatively 
small and especially in relatively wealthier nations.  
 The effects of HIV/AIDS on saving are mixed regarding relatively wealthy versus 
relatively poor countries: wealthier countries have more mechanisms and better infrastructure to 
cope with this epidemic, while on the other hand proportionately poor countries are more 
negatively affected by this epidemic due to the low amount of available resources.  
 
                                                 
4 http://financialplan.about.com/cs/funerals/ 
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Effects on Investment 
 Moatti et al., [2003] and Hacker [2002] stress the fact that the cost effectiveness of 
treating this epidemic determines the impact on saving and/or investment in any given country. 
Private businesses investing in worker education and treatment of this epidemic will ultimately 
have costs that are lower than the costs associated with the loss of experienced workers, 
increased absenteeism, reduced productivity, and many other negative effects. The implications 
would be that we should see a transfer of investment from wealthier to relatively poorer 
countries whereby a firm's headquarters would transfer funds to its international subsidiaries.  
 George and Whiteside [2002], and Glenn [2003] support the claim that a company’s 
investment in prevention and care will positively affect investment in developing nations; this is 
most obvious in the mining industry in Africa.  According to George and Whiteside [2002], in 
1999, 75% of retirements and 59.1% of deaths in that industry were due to HIV/AIDS.  Since 
companies in this area have taken bold steps in co-operation with workers to help with treatment 
costs, firms have experienced an increase in productivity and a decrease in the cost of hiring, 
training, and retirement payments. 
 Bloom et al. [2001] provide many examples of firms not only investing in their workers 
and the worker's families, but also community action programs dedicated to informing the public 
about the disease as well as providing community investment. A significant portion of these 
companies are headquartered in relatively wealthy countries. This implies that they are 
essentially exporting investment to relatively poor countries to cover the costs of these projects 
as well as worker treatment programs. Empirically we may actually see that any negative impact 
on investment in poorer countries could be mitigated by the inflow of investment from wealthier 
countries.  
 6
Our Study 
 This paper is essentially a direct extension of Edwards and Al-Hmoud [2004] where they 
stratify the data by per capita income over a large cross-section of countries to evaluate the 
relationship between growth and HIV/AIDS. In their study they found that the impact infections 
and mortality has on growth varies considerably over income groups. As most studies suggest, 
they found that poor countries are negatively impacted by infections and mortality, but that this 
relationship actually reverses as countries grow wealthier. They hypothesized that the growth in 
the industry surrounding the epidemic in rich countries must be outweighing the negative impact 
from the depletion of vital resources such as loss of labor.  
 Cuddington [1993] originally adapted the use of the Solow [1956] growth model to 
address the impact HIV/AIDS has on saving. His study focused on trying to estimate future 
impacts on economic variables with regard to the case study of Tanzania. Using a series of 
simulations, and extrapolating to the year 2010, he found that as domestic saving fell because of 
the expense of AIDS-related medical costs and losses in worker productivity, GDP in Tanzania 
could fall by as much as 15 to 25 percent. In his study, however, he actually chooses the value of 
the parameter that estimates the reduction in saving. In fact, Cuddington states that ". . . no 
estimate of the effect of AIDS on private or public saving is available."  
 In our study, we find that HIV/AIDS infections and mortality has a positive effect on 
saving in relatively wealthy countries and a negative relationship in relatively poor countries. 
The nexus between HIV/AIDS and investment is not as clear. Our results indicate that there is 
not a relationship in either the poorest or the wealthiest of countries; only the second-tier (out of 
four income brackets) has a statistically significant and negative relationship but with a greatly 
reduced magnitude from what one would expect. Given that the poorest of countries are the ones 
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most affected, we hypothesize that the argument above for the transfer of funds from 
corporations in relatively wealthy countries to subsidiaries in poorer countries is possibly a 
partial explanation.  
 The paper is arranged as follows. Section 1 addresses the specific form of the 
econometric model with particular modifications, the testing methods used to assure that our 
results are statistically adequate, and the reasoning behind our stratification of the data. Section 2 
discusses the data while Section 3 tables the results and section 4 draws a conclusion.  
 
1. The Model 
 The econometric model that we use is a simple ordinary least squares regression with 
particular modifications. Specifically, the model takes the forms 
it1t,i61t,i5
1t,i41t,i31t,i21t,i1r0it
eIndGrowthaPopGrowtha
LiteracyaGDPaGrowthaInfectionaaInvestment



              (1) 
it1t,i61t,i5
1t,i41t,i31t,i21t,i1r0it
uIndlGrowthbPopGrowthb
LiteracybGDPbGrowthbInfectionbbSaving



                    (2) 
it1t,i61t,i5
1t,i41t,i31t,i21t,i1r0it
vIndGrowthcPopGrowthc
LiteracycGDPcGrowthcMortalitybcInvestment



              (3) 
it1t,i61t,i5
1t,i41t,i31t,i21t,i1r0it
rIndGrowthdPopGrowthd
LiteracydGDPdGrowthdMortalityddSaving



 .                 (4) 
 The ‘Growth’ variable is the annual growth rate in per capita real GDP, ‘GDP’ is per 
capita real GDP, ‘Literacy’ is the percentage of the population 15 years and older who can read 
and write, ‘PopGrowth’ is annual percentage population growth, and ‘IndGrowth’ is an annual 
percentage measure of industrial growth. ‘Infection’ is defined as the number of people infected 
with HIV/AIDS per thousand of population, while the ‘Mortality’ variable is the number of 
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deaths attributable to HIV/AIDS per thousand of population. As for the dependent variables, 
‘Saving’ is defined as gross domestic savings as a percentage of GDP, and ‘Investment’ is 
defined as gross domestic investment as a percentage of GDP.5 
 Several features of these models should be noticed. First, the constant terms in each 
model vary by region as delineated by the Penn World Tables (PWT) version 6.1 [Heston, et al., 
2002]. Controlling for regionally-specific fixed effects has been shown to be a significant 
statistical issue in empirical models [Edwards and McGuirk, 2004; Edwards, 2005]. We do not 
estimate this with country-specific effects for a couple of reasons. One reason is that per the 
PWT 6.1, there are 15 defined regions for which to capture much of the mean heterogeneity 
across countries. The other reason pertains to the fact that we would like to keep the degrees of 
freedom as high as possible; if we were to estimate country-specific fixed effects, the degrees of 
freedom would be TI-I-K (T is the total number of years covered, I is the total number of 
countries, and K is the number of estimated determinants [see Wooldridge, 2003]). In our case, 
with T=2 and the number of observations in each income bracket only around 40, the resulting 
degrees of freedom would be too small to gain reliable inference from our results. Second, to 
control for possible feedback from investment or saving to the control variables, we lagged all 
right-hand-side variables by one year. Barro consistently uses lagged determinants as instruments 
to control for feedback [e.g., Barro, 1996], with Temple [1999] suggesting that this is the best 
solution to the problem.  
 Regressions (1) - (4) are also stratified by per capita real GDP. This is important because 
we would expect the coefficients of the infection and mortality variables to vary from developing 
                                                 
5 The formal definitions of these variables from the World Banks' World Development Indicators, 2004, edition is as 
follows: gross domestic savings are calculated as GDP less final consumption expenditure; gross domestic 
investment consists of outlays on additions to the fixed assets of the economy plus net changes in the level of 
inventories. 
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to developed nations. For example, we might expect the coefficient for the mortality variable in 
regression (4) to be negative, but to rise or fall in absolute value as we move to a higher income 
bracket because of the cash cost of burials relative to income in wealthier nations. There is also 
no reason to assume that any of the control variables would have the same impact on saving or 
investment in poor countries as they would in wealthy countries. Even if the coefficient estimates 
on the control variables could be statistically accepted as being equal across income levels, 
asserting economic equality would be a stretch. Hence, capturing the purest effects of HIV/AIDS 
on investment and saving must require that all variables are allowed to vary across income 
levels.   
 The process we use for the stratification procedure is somewhat ad hoc, but has statistical 
appeal. We start from the lowest per capita GDP observations and increase the sample by $100 
increments until (after accounting for the determinants and the regional effects) a rule-of-thumb 
30 degrees of freedom can be maintained. This lends itself to four layers of stratification for the 
income groups; less than $400 per capita GDP, $400 to $1200, $1200 to $4000, and greater than 
$4000. This stratification was determined for models (1) and (3) with the same stratification used 
for models (2) and (4). The sample sizes for these brackets are 41, 43, 40, and 38 observations 
respectively. This stratification is a direct extension of Edwards and Al-Hmoud [2004]. 
 We acknowledge that there could be many more control variables added to the 
regressions, but due to the size of our data set and to the fact that we stratify by income levels, 
we had to be selective. All of the included control variables in the regressions exist to try to 
correct for possible dependence between the residuals and the infection and mortality variables. 
For instance, it is obvious to assume that per capita GDP would both be correlated with the 
number of infections as well as the number of mortalities. It is commonly thought that as 
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countries become more developed, the percentage of the population infected with the disease 
diminishes.  It is also obvious to assume that per capita GDP may be correlated with investment 
and saving. If per capita GDP were not included, a theoretical breakdown of the independence 
assumption would result. Not only will the other control variables have similar reasons for their 
entry into our models but the standard regressors of population growth, GDP, and growth are 
common in the literature [see Levine and Renelt, 1992]. 
 We chose to include a measure of illiteracy in our control group instead of the commonly 
chosen education or schooling variables because as shown by Rojanapithayakorn [1994], the 
ability to read is all that is needed to impact the number of HIV infections. In fact, it was shown 
that in Thailand--where formal schooling is low, an increase in infection awareness campaigns 
resulted in an approximately 45% increase in condom use among sex workers (Bloom and Mahal 
[1997], and Edwards and Al-Hmoud [2004] also use a similar variable in their regressions). 
 To determine the statistical adequacy of our models given our small sample sizes, we use 
a battery of statistical testing procedures to assure that the typical normal and identically 
distributed assumptions of the errors in equations (1) - (4) hold. This will not only assure us that 
our estimates are unbiased and consistent, but that all test statistics are valid--at least to the 
degree that our data does not exhibit serially correlated errors which we control for in a limited 
manner by separating our data by one year (achieving a larger spread was not possible due to the 
availability of the data). But even if the errors are serially correlated, the estimators are still 
unbiased and consistent; standard errors will be biased [Baltagi, 2001]. To test for omitted 
variables (i.e., non-linear determinants) we use the Regression Specification Error Test (RESET) 
developed by Ramsey [1969]; to test for homoskedasticity we use the White's [1980] test which 
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does not require the assumption of normality; to test for a normal conditional distribution, we test 
for the third moment (skew) being equal to zero, and the fourth moment (kurtosis) equal to three.  
 In addition to these basic tests, because parametric heterogeneity has become a 
significant issue in empirical work [Yang and Edwards, 2005; Durlauf et al., 2001; Bosworth and 
Collins, 2003], we employ the Hansen test [Hansen, 1992]. Of course this test was meant for 
testing parametric stability in time series work, but is easily adaptable for cross-sectional studies 
as long as a coherent ordering is maintained. It has been shown in recent studies that parameters 
are likely to vary by region [Edwards, 2005] and/or by initial levels of per capita GDP [Durlauf, 
et al., 2001]. To this end, we order our data by regional levels of lagged per capita GDP to 
capture both effects. 
 
2. The Data 
       The data we use comes from two sources. The infection and mortality variables are 
acquired from the CIA's World Fact book. While we admit that this data is suspect as to its 
accuracy, multi-year data on AIDS mortality is hard to come by. We get the dependent variables 
and the control variables from the World Bank's World Development Indicators, 2004, database.  
 The saving and investment variables are for the years 2000 and 2002, while the 
dependent variables are for the years 1999 and 2001. There are a total of 162 observations 
covering 85 countries resulting in an average of 1.9 observations per country. Our data covers a 
broad range of countries according to per capita levels of GDP and are listed according to the per 
capita GDP stratification in Appendix A. 
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3. The Results 
 As a precursor to the stratified regressions, Table 1 displays the estimates from 
regressions (1) - (4) that are pooled across income levels. The estimates confirm the belief that 
on average HIV/AIDS does indeed lower investment and saving in a statistically significant 
manner. Having said this, it does appear as though the consequence on saving is almost twice 
that of investment. Accounting for this may be the fact that the investment variable as measured 
does include levels of foreign direct investment which would be partially offsetting the total 
effect as seen in the domestic saving estimate. It is also interesting to note that mortality affects 
investment about 12 times more than infections, while impacting saving about 9 times more than 
infections. To explain this phenomenon at this stage would be futile because as will be seen in 
Tables 2 and 3 below, this relationship varies considerably across income levels.  
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Table 1: Pooled Regressions 
 Investment Saving 
 
Infection 
 
 
Mortality 
 
 
IndGrowth 
 
 
Growth 
 
 
PopGrowth 
 
 
Literacy 
 
 
GDP 
 
 
Cons 
 
-0.068 ** 
(0.000) 
 
 
 
 
0.141 * 
(0.093) 
 
0.763 ** 
(0.000) 
 
0.638 
(0.391) 
 
0.033 
(0.285) 
 
0.003 
(0.961) 
 
15.664 ** 
(0.000) 
 
 
 
 
-0.819 ** 
(0.000) 
 
0.136 
(0.102) 
 
0.746 ** 
(0.000) 
 
0.679 
(0.358) 
 
0.028 
(0.361) 
 
0.002 
(0.970) 
 
16.092 ** 
(0.000) 
 
-0.153 ** 
(0.000) 
 
 
 
 
-0.0006 
(0.996) 
 
0.194 
(0.467) 
 
-1.029 
(0.399) 
 
0.084 
(0.109) 
 
0.202 * 
(0.063) 
 
9.929 * 
(0.079) 
 
 
 
 
-1.447 ** 
(0.000) 
 
-0.018 
(0.904) 
 
0.189 
(0.490) 
 
-0.954 
(0.443) 
 
0.078 
(0.146) 
 
0.217 ** 
(0.049) 
 
9.876 * 
(0.087) 
 
RESET 
 
White 
 
Skew 
 
Kurtosis 
 
Hansen: 
Infection 
Mortality 
Ind. Prod. 
Growth 
Population 
Literacy 
GDP 
 
No. of Regions 
 
0.560 
 
0.019 
 
0.362 
 
0.235 
 
 
0.041 
 
0.077 
0.057 
0.029 
0.062 
0.419 
 
2 
 
 
0.568 
 
0.057 
 
0.429 
 
0.257 
 
 
 
0.048 
0.074 
0.061 
0.035 
0.071 
0.409 
 
2 
 
0.133 
 
0.000 
 
0.290 
 
0.010 
 
 
0.033 
 
0.273 
0.168 
0.089 
0.093 
0.160 
 
3 
 
0.586 
 
0.000 
 
0.258 
 
0.009 
 
 
 
0.031 
0.283 
0.199 
0.100 
0.113 
0.144 
 
3 
Dependent variable is marked at the column heading. In the first row are the coefficient estimates with P-values in 
parentheses. * implies significance at 10%, ** implies significance at 5%.  The second row contains p-values for the 
first four tests and Hansen statistics below. A value of 0.47 or greater for the Hansen statistic indicates that the null 
of a stable coefficient is not a valid assumption at the 5% level.  
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 The results for the stratified regressions are shown below. Table 2 lists the estimates and 
test statistics for the stratified saving regressions while Table 3 lists the estimates for the 
investment regressions. In each table, the income brackets are labeled in the top row, coefficient 
estimates in the second row, and test statistics in the third row. It is important to note that to 
correct for parametric instability in the saving/mortality regression for the   $400 bracket, an 
interaction between the region of South Africa and growth had to be included. The original 
Hansen statistic for growth was 0.519, above the 0.47, 5% cutoff. Also because of a failure of the 
RESET test for the saving model in the $400 to $1200 income bracket, a respecification of the 
model that included an interaction between population growth and both infections and mortality 
was required. For increased readability, Tables 2 and 3 simply list the coefficient estimates on 
the infection and mortality variables with the control estimates listed in Appendix B.  
      What Table 2 shows is that there is definitely a significant amount of income 
heterogeneity in coefficient estimates for the infection and mortality estimates (Appendix B also 
depicts a significant amount of heterogeneity across the control variable estimates). It seems as 
though much of the negative relationship in Table 1 was driven by correlations for the poorest of 
countries. Having said this, there are even more important results from the stratified regressions 
that should be brought to light. 
 
 
 
 
 
 
 15
 
Table 2: Results for Saving Regressions (2) and (4) 
 
Variables   $400 $400 - $1200 $1200 - $4000 > $4000 
 
Infection 
 
 
InfectionX 
Population 
 
 
Mortality 
 
 
MortalityX 
Population 
 
 
 
-0.111 ** 
(0.042) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-1.219 ** 
(0.026) 
 
-0.584 ** 
(0.000) 
 
0.240 ** 
(0.001) 
 
 
 
 
 
 
 
 
-8.148 ** 
(0.000) 
 
3.548 ** 
(0.000) 
 
0.029 
(0.295) 
 
 
 
 
 
 
 
 
0.443 
(0.247) 
 
0.093 ** 
(0.018) 
 
 
 
 
 
 
 
 
1.199 ** 
(0.015) 
 
RESET 
 
White 
 
Skew 
 
Kurtosis 
 
Hansen: 
Infection 
Mortality 
Ind. Prod. 
Growth 
Population 
Literacy 
GDP 
 
No. of 
Regions 
 
0.732 
 
0.606 
 
0.948 
 
0.220 
 
 
0.090 
 
0.044 
0.154 
0.049 
0.045 
0.073 
 
0 
 
0.761 
 
0.661 
 
0.963 
 
0.209 
 
 
 
0.135 
0.040 
0.180 
0.049 
0.044 
0.070 
 
0 
 
0.066 
 
0.428 
 
0.120 
 
0.067 
 
 
0.085 
 
0.213 
0.179 
0.089 
0.133 
0.096 
 
2 
 
0.074 
 
0.428 
 
0.306 
 
0.239 
 
 
 
0.034 
0.217 
0.161 
0.198 
0.087 
0.103 
 
2 
 
0.687 
 
0.425 
 
0.111 
 
0.813 
 
 
0.024 
 
0.116 
0.122 
0.093 
0.068 
0.099 
 
3 
 
0.613 
 
0.425 
 
0.083 
 
0.768 
 
 
 
 
0.024 
0.105 
0.129 
0.098 
0.072 
 
3 
 
0.737 
 
0.423 
 
0.759 
 
0.123 
 
 
0.018 
 
0.248 
0.059 
0.337 
0.249 
0.229 
 
4 
 
0.759 
 
0.423 
 
0.746 
 
0.122 
 
 
 
0.020 
0.074 
0.117 
0.022 
0.068 
0.218 
 
4 
 
Dependent variable is domestic savings. In the first row are the income bracket delineations; in the second row are 
the coefficient estimates with P-values in parentheses. * implies significance at 10%, ** implies significance at 5%.  
The third row contains p-values for the first four tests and Hansen statistics below. A value of 0.47 or greater for the 
Hansen statistic indicates that the null of a stable coefficient is not a valid assumption at the 5% level. 
 
 The test statistics in Table 2 tells us that all four models have the usual, desirable 
statistical properties. All of the standard distributional tests have p-values well above 0.05, and 
the Hansen statistics are all well below the 5% cutoff of 0.47. In combination, we can be assured 
that our models are statistically adequate with regard to distribution and parametric stability. 
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Three of the four models have at least 30 degrees of freedom, while the highest income group 
fell three degrees of freedom short of our objective. Since the common rule of 30 degrees is 
simply a 'rule-of-thumb', we do not find this particularly troubling. 
 Also of considerable interest is the fact that the relationship between both infections and 
mortality, and saving is non-linear with respect to population growth for the $400-$1200 bracket. 
For countries in this income bracket that have population growth rates below 2.433% and 
2.296% respectively, the impact on saving from infections and mortality respectively is negative, 
but reverses for population growth rates above these levels. According to our data, 25 countries 
have average population growth rates above 2.296% and 15 are above 2.433%.6 The only 
plausible explanation must reside in the simple thought that for these countries, the fast growing 
population must be adding to saving faster than the loss of saving from a decreasing population. 
One of the only ways an argument like this would hold water is if the majority of the countries 
with high population growth rates also had relatively low saving so any addition to saving by a 
rapidly growing work force would weigh heavily.  
 For the infections group, out of the 25 countries above 2.296% population growth 19 of 
the countries are in the bottom 50% of saving, while for the mortality group 13 of the 15 
countries are in the bottom 50% of saving. Nevertheless, in general, the pattern of the 
coefficients across income groups is in agreement with the findings of Edwards and Al-Hmoud 
[2004]; the relationship between infections and mortality on saving is negative for low income 
countries, but reverses for wealthier countries.  
 We also see that the absolute values of the coefficients for mortality are considerably 
larger than for illness. We believe that for the ‘low’ and ‘middle’ income groups, this is due to 
                                                 
6 The 15 countries are Burkina Faso, Swaziland, Benin, Guatemala, Nicaragua, Honduras, Angola, Guinea-Bissau, 
Mauritania, Namibia, Rwanda, Uganda, Madagascar, Chad, and Belize. The remaining 10 countries are Senegal, 
Malaysia, Cote d'Ivoire, Tanzania, Ethiopia, Djibouti, Gabon, Mali, Pakistan, and Nigeria.  
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the fact that taking care of an infected individual reduces saving gradually over a period of time, 
even though the total cost of care may be quite significant. Furthermore, a depletion of saving 
due to a family member taking care of a sick-loved one may not require that the family member 
completely drop out of the workforce—this individual may still be able to work part-time. This 
also holds true for the infected individuals themselves. Since being infected with the disease does 
not require that the individual be morbid, that individual may still work their regular jobs even 
though at a decreased level of productivity. 
 When the individual passes away, the funeral expenses are a one-time, contemporaneous 
depletion of resources and would impact saving to a much greater extent than would the 
infection. These explanations only pertain to the negative relationship for the 'low' and 'middle' 
income groups, and will not suffice for the differences in magnitudes for the ‘high’ income group 
and their positive coefficients. 
 While the signs of the coefficients on infections and mortality in the 'high' income case 
can be rationalized with Bonnel’s reasoning, the difference in magnitudes cannot. We believe the 
reason the infections coefficient is much smaller than the mortality coefficient is due to two 
factors. Precautionary saving increases as the number of infections rises due to the probability 
that any one particular individual may become infected. This will be true if an individual thinks 
that their sexual behavior results in a positive probability that they may become infected. As the 
number of mortality cases increases, these individuals and their families start saving for not only 
the relatively high, one-time expense of funeral costs, but also because of the complete loss of 
income from the infected individual.   
 The general conclusion one can draw from Table 2 is that there does exist a statistically 
significant amount of heterogeneity in both the infections and mortality coefficients as you move 
 18
from relatively poor to relatively wealthy countries. This reversing of the impact of HIV/AIDS 
on saving tends to support Bonnel's [2000] claim that the disease may actually increase saving at 
least for wealthier countries.  
 His belief is that because many households would experience greater income variability, 
they would increase saving as a precaution to satisfy future medical and funeral expenses, and a 
loss of income when the diseased individual passes away--especially in countries where the HIV 
epidemic is well-established. This is in contrast to poorer countries whose populations may not 
have the income to support much saving at all and would have to deplete existing resources 
without being able to adjust their ability to save. The establishment of the disease is critical to 
Bonnel's claim. It is commonly known that HIV/AIDS was first diagnosed in the United States in 
1981, and soon thereafter Western Europe and sub-Saharan Africa [Bongaarts, 1996]. It was not 
until later that the disease started becoming a problem in other developing areas of the world, 
with statistically significant negative effects not seen until the late 1990's [Dixon, et al., 2001]. 
The results from the investment regressions are shown below. 
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Table 3: Results for Investment Regressions (1) and (3) 
Variables   $400 $400 - $1200 $1200 - $4000 > $4000 
 
Infection 
 
 
Mortality 
 
 
 
-0.012 
(0.832) 
 
 
 
 
-0.390 
(0.539) 
 
-0.068** 
(0.014) 
 
 
 
 
-1.019** 
(0.001) 
 
0.065 
(0.140) 
 
 
 
 
 
0.656 
(0.166) 
 
-0.024 
(0.169) 
 
 
 
 
 
 
-0.322 
(0.162) 
 
RESET 
 
White 
 
Skew 
 
Kurtosis 
 
Hansen: 
Infection 
Mortality 
Ind. Prod. 
Growth 
Population 
Literacy 
GDP 
 
No. of 
Regions 
 
0.066 
 
0.426 
 
0.112 
 
0.292 
 
 
0.160 
 
0.022 
0.109 
0.025 
0.020 
0.029 
 
3 
 
 
0.057 
 
0.426 
 
0.094 
 
0.296 
 
 
 
0.116 
0.029 
0.108 
0.024 
0.022 
0.031 
 
3 
 
0.271 
 
0.428 
 
0.572 
 
0.382 
 
 
0.085 
 
0.213 
0.179 
0.089 
0.133 
0.096 
 
5 
 
0.415 
 
0.428 
 
0.608 
 
0.406 
 
 
 
0.090 
0.081 
0.182 
0.064 
0.045 
0.041 
 
5 
 
0.238 
 
0.425 
 
0.125 
 
0.612 
 
 
0.033 
 
0.101 
0.043 
0.036 
0.024 
0.044 
 
2 
 
0.313 
 
0.425 
 
0.114 
 
0.643 
 
 
 
0.021 
0.106 
0.045 
0.033 
0.024 
0.038 
 
2 
 
0.660 
 
0.432 
 
0.082 
 
0.623 
 
 
0.076 
 
0.095 
0.094 
0.081 
0.096 
0.135 
 
0 
 
0.655 
 
0.407 
 
0.083 
 
0.614 
 
 
 
0.060 
0.097 
0.093 
0.080 
0.095 
0.133 
 
0 
Dependent variable is the investment to GDP ratio. In the first row are the income bracket delineations; in the 
second row are the coefficient estimates with P-values in parentheses. * implies significance at 10%, ** implies 
significance at 5%.  The third row contains p-values for the first four tests and Hansen statistics below. A value of 
0.47 or greater for the Hansen statistic indicates that the null of a stable coefficient is not a valid assumption at the 
5% level. 
 
 With the exception of the $400 to $1200 bracket, neither infections nor mortality have 
any statistically significant impact on investment. One hypothesis related to these results may 
simply be that the establishment and upkeep of capital for multi-national subsidiaries in 
developing countries requires a movement of investment resources from developed to 
developing countries; this would be the standard economic explanation. However, there is also 
reason to believe that a sufficiently large transfer of investment resources would be for treatment 
and education programs as well as economic enhancement programs for communities impacted 
by the disease.  
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 Bloom et al. [2001], give numerous examples of multinational firms investing in 
developing nations to address the disease. For example, the International HIV/AIDS Alliance 
and businesses like Levi-Strauss, Glaxo-Wellcome, MTV International, and Tanqueray, are 
actively investing in community education and development programs in regions such as Latin 
America, Asia, and Africa. Glaxo-Wellcome's prevention and education program covers all of 
its' 55,000 employees world wide. Polaroid started an 'intensive' employee education program in 
1987. Chevron, Nigeria Ltd., has invested heavily in its' 2,600 employees and the community 
with such programs as the Chevron Workplace AIDS Prevention Program, and the Chevron 
Adolescent Reproductive Health Program. There are many other multi-national firms taking part 
as well; Standard Chartered Bank (Paris) with over 570 offices in 50 countries many of which 
are in Africa; International Hotel and Restaurant Association (Paris) with over 750,000 
operators, associations, and suppliers in more than 150 countries; Bristol-Myers Squibb 
Company (USA) with nearly 54,000 employees; and the list goes on.7  
 These programs may be either directly or indirectly investment enhancing. Directly, it 
seems reasonable to assume that many of these well-funded projects dedicated to employees, 
families, and the community provide direct investment in the form of fixed assets such as land 
improvements, schools, offices, hospitals, residential dwellings, etc. Indirectly, the education of 
the workforce would result in greater worker productivity and reduced absenteeism thus leading 
to increased inventories if the firms so choose. This would be particularly true in the mining 
industries. 
 It is obvious that there is a large transfer of resources from firms headquartered in 
wealthy nations to their subsidiaries and the communities in which their subsidiaries reside in 
                                                 
7 Bloom et al. [2001] cite many authors as the sources for these examples. Please see their paper for the large list of 
citations.  
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relatively poor nations. However, there may be an argument based on our results in Table 3 that 
for countries with incomes between $400 and $1200, this phenomenon is not occurring given 
that the affect of the disease in investment is statistically significant and negative. In order to 
compare apples and apples with the saving results by viewing the simple correlation between the 
two variables instead of the interaction, the infections estimate for the saving regression is -0.273 
and -3.01 for the mortality estimate. Given that the estimates for investment are much lower in 
absolute value, it seems reasonable to conclude that even though the transfer of funds is of order 
of magnitude lower than in the less than $400 group, it is still occurring just to a lesser extent.  
  
4.  Conclusion 
 In conclusion, this study has brought several interesting hypotheses to light. The first is 
that there does seem to be a significant amount of heterogeneity across income groups with 
regard to the impact that HIV/AIDS has on real economic variables. The second is that with 
regard to saving, the implied claims stated earlier that tell a tale of precautionary saving in 
wealthy countries and disproportionately negative effects due to the availability of resources in 
relatively poor countries, could very well be valid hypotheses. We have also found evidence 
supporting our hypothesis that a significant transfer of resources from firms in wealthy countries 
to subsidiaries, workers, and communities in poor countries are probably lessening the extent to 
which investment in poorer nations are impacted by the disease.  
A possible policy implication of this study would to encourage even stronger support for 
employee and community education, treatment, and economic programs by multi-national firms 
for their developing country subsidiaries. This would help alleviate the decimation to saving that 
exists in those countries from medical and funeral expenses. Workers gaining in not only the 
 22
education of disease awareness, but also education in general and increased worker longevity can 
only be seen as growth and saving enhancing.  
 Further research in this area should occur as more data becomes available. But should 
also be directed at possibly separating the extent to which this transfer of funds helps private 
sector growth, versus reduced governmental burden in these developing countries that are 
hardest hit by the disease.  
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Appendix A 
 
Countries for each income bracket: 
 
< $400 GDP $400 - $1,200 GDP $1,200 - $4,000 GDP > $4,000 GDP 
 
Bangladesh 
Burkina Faso 
Burundi 
Central African Rep. 
Chad 
Ethiopia 
Ghana 
Guinea-Bissau 
Haiti 
Kenya 
Madagascar 
Malawi 
Mali 
Mozambique 
Nigeria 
Rwanda 
Sierra Leone 
Sudan 
Tanzania 
Uganda 
Vietnam 
Zambia 
 
 
Angola 
Benin 
Bolivia 
Cameroon 
China 
Cote d'Ivoire 
Djibouti 
Ghana 
Guinea 
Guyana 
Honduras 
India 
Indonesia 
Lesotho 
Mauritania 
Nicaragua 
Pakistan 
Philippines 
Senegal 
Sri Lanka 
Ukraine 
Zambia 
Zimbabwe 
 
 
Belarus 
Belize 
Botswana 
Colombia 
Costa Rica 
Dominican Rep. 
Ecuador 
El Salvador 
Guatemala 
Mexico 
Namibia 
Panama 
Paraguay 
Peru 
Romania 
Russia 
South Africa 
Suriname 
Swaziland 
Thailand 
Venezuela 
 
Argentina 
Barbados 
Botswana 
Brazil 
Canada 
Chile 
France 
Gabon 
Germany 
Italy 
Japan 
Korea 
Malaysia 
Netherlands 
Portugal 
Singapore 
Spain 
Switzerland 
Trinidad and Tobago 
United Kingdom 
United States 
Uruguay 
 
The countries of Ghana, Zambia, and Botswana appear in two separate income brackets. This is due to the fact that 
their income per capita status changed from 2000 to 2002. 
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Appendix B 
 
Control Variable Estimates for Saving Regressions (2) and (4) 
 
Variables   $400 $400 - $1200 $1200 - $4000 > $4000 
 Infect. Mort. Infect. Mort. Infect. Mort. Infect. Mort. 
 
IndGrowth 
 
 
Growth 
 
 
GrowthSAfr. 
 
 
PopGrowth 
 
 
Literacy 
 
 
GDP 
 
0.272 
(0.272) 
 
0.409 
(0.307) 
 
1.836 
(0.008) 
 
-5.578 
(0.072) 
 
0.126 
(0.101) 
 
45.337  
(0.015) 
 
 
0.310 
(0.210) 
 
0.351 
(0.378) 
 
1.679 
(0.011) 
 
-5.174 
(0.088) 
 
0.116 
(0.121) 
 
48.171 
(0.008) 
 
0.172 
(0.617) 
 
0.188 
(0.767) 
 
 
 
 
-3.651 
(0.138) 
 
-0.004 
(0.972) 
 
7.514 
(0.443) 
 
0.047 
(0.892) 
 
0.180 
(0.785) 
 
 
 
 
-3.236 
(0.202) 
 
0.017 
(0.887) 
 
5.748 
(0.577) 
 
-0.046 
(0.785) 
 
-0.058 
(0.887) 
 
 
 
 
1.715 
(0.488) 
 
-0.412 
(0.138) 
 
10.243 
(0.000) 
 
-0.055 
(0.746) 
 
-0.063 
(0.876) 
 
 
 
 
1.645 
(0.504) 
 
-0.392 
(0.161) 
 
10.127  
(0.000) 
 
0.189 
(0.281) 
 
1.102  
(0.003) 
 
 
 
 
3.392 
(0.179) 
 
0.186 
(0.531) 
 
0.206  
(0.030) 
 
0.193 
(0.267) 
 
1.094 
(0.003) 
 
 
 
 
3.412 
(0.173) 
 
0.182 
(0.530) 
 
0.210 
(0.026) 
 
Adj. R2 
 
0.488 
 
0.501 
 
0.600 
 
0.568 
 
0.537 
 
0.541 
 
0.785 
 
0.788 
Dependent variable is domestic savings. In the first row are the income bracket delineations; in the second row are 
the coefficient estimates with P-values in parentheses.  
 
 
Control Variable Estimates for Investment Regressions (1) and (3) 
 
Variables   $400 $400 - $1200 $1200 - $4000 > $4000 
 Infect. Mort. Infect. Mort. Infect. Mort. Infect. Mort. 
 
IndGrowth 
 
 
Growth 
 
 
PopGrowth 
 
 
Literacy 
 
 
GDP 
 
0.030 
(0.903) 
 
0.998 
(0.007) 
 
6.479 
(0.060) 
 
0.025 
(0.751) 
 
6.034 
(0.723) 
 
0.024 
(0.923) 
 
0.980 
(0.008) 
 
6.262 
(0.062) 
 
0.022 
(0.783) 
 
6.881 
(0.683) 
 
0.821 
(0.000) 
 
0.176 
(0.646) 
 
-1.365 
(0.519) 
 
0.082 
(0.290) 
 
-9.876 
(0.196) 
 
0.734 
(0.000) 
 
0.092 
(0.793) 
 
-1.737 
(0.378) 
 
0.089 
(0.219) 
 
-10.697 
(0.135) 
 
-0.092 
(0.265) 
 
0.319 
(0.131) 
 
3.297 
(0.001) 
 
0.467 
(0.000) 
 
-1.490 
(0.073) 
 
-0.103 
(0.213) 
 
0.322 
(0.129) 
 
3.289 
(0.001) 
 
0.465 
(0.000) 
 
-1.523 
(0.069) 
 
0.239 
(0.020) 
 
0.626 
(0.002) 
 
-0.620 
(0.580) 
 
-0.396 
(0.000) 
 
0.083 
(0.072) 
 
0.239 
(0.019) 
 
0.627 
(0.002) 
 
-0.646 
(0.565) 
 
-0.402 
(0.000) 
 
0.083 
(0.072) 
 
Adj. R2 
 
0.391 
 
0.397 
 
0.604 
 
0.653 
 
0.354 
 
0.348 
 
0.621 
 
0.622 
Dependent variable is domestic savings. In the first row are the income bracket delineations; in the second row are 
the coefficient estimates with P-values in parentheses.  
 
 
 
 
 
 
 
